Your browser doesn't support javascript.
loading
Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway.
Li, Dan; Shen, Yanwei; Ren, Hui; Wang, Li; Yang, Jin; Wang, Yuan.
Afiliación
  • Li D; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Shen Y; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Ren H; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Wang L; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Yang J; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. yangjin@mail.xjtu.edu.cn.
  • Wang Y; Department of Medical Imaging, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China. Yuanw_123@163.com.
J Bioenerg Biomembr ; 53(3): 295-305, 2021 06.
Article en En | MEDLINE | ID: mdl-33712992

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína Smad2 / Carcinoma Pulmonar de Células Pequeñas / Angiomotinas / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: J Bioenerg Biomembr Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína Smad2 / Carcinoma Pulmonar de Células Pequeñas / Angiomotinas / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: J Bioenerg Biomembr Año: 2021 Tipo del documento: Article País de afiliación: China